Taking stock of the drug industry, from the lab to the medicine chest STAT+: Pharma donations to patient charities may violate the 'spirit' of anti-kickback laws By Ed Silverman Alex Welsh/The New York Times “This ability to make a donation allows manufacturers being able to subsidize their own drug," said Leemore Gafney of Harvard Business School. Read More STAT+: Bayer agrees to $40 million settlement over kickbacks and downplaying drug safety risks By Ed Silverman APStock The settlement ends years of litigation in which a former marketing employee battled Bayer over its practices. Read More Pfizer isn't sharing Covid vaccines with researchers for next-gen studies By Rachel Cohrs Eugene Hoshiko/AP Researchers studying next-gen vaccines to fight an evolving Covid threat are running into problems getting existing vaccines to study. Read More Sponsor content by STAT Events When the Barrier to a Breakthrough Drug is You Can't Make It On Sept 28, hear how developers have approached the manufacturing process to bring new and innovative treatments to patients. Register for free. STAT+: Why Illumina has a merger mess of its own making By Matthew Herper Molly Ferguson for STAT At the start, there was a kind of “heads you lose, tails I win” kind of logic about Illumina’s decision to close the Grail purchase. Read More STAT+: Doctors, seniors groups flag concerns with Medicare Advantage By Bob Herman Pablo Martinez Monsivais/AP They argue the growing government program is failing seniors and making life miserable for doctors and other providers. Read More White House signals most people will only need annual Covid booster By Andrew Joseph Drew Angerer/Getty Images The messaging about the new bivalent vaccines reflects another transition point in the country's fight against the coronavirus. Read More Google debuts a new AI tool in the global fight against tuberculosis By Casey Ross NOAH SEELAM/Getty Google is joining the global fight to snuff out tuberculosis, using AI to automate its detection and expedite treatment. Read More Opinion: The FDA got it right with hearing aids. Updating Medicare coverage is next By Nicholas S. Reed and Frank R. Lin Joe Raedle/Getty FDA regulations on OTC hearing aids are a big step forward. Now Medicare needs to cover them, and hearing services provided by audiologists. Read More Tuesday, September 6, 2022 1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser
No comments